companiesandmarkets.com

Summary: ImClone Systems Incorporated - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.

ImClone Systems (ImClone) is a biopharmaceutical company specializing in the development of therapeutic products for the treatment of cancer and cancer-related disorders, as well as diagnostic products and vaccines for a number of infectious diseases. ImClone is headquartered in New York City, New York and employs about 1,000 people. The company recorded revenues of $590.8 million during the fiscal year ended December 2007, a decrease of 12.8% over 2006. The operating profit of the company was $51.5 million during fiscal year 2007, compared to an operating profit of $289.2 million in 2006. The net profit in fiscal year 2007 was $39.8 million, compared to a net profit of $370.7 million in 2006.

Scope of the Report

- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement

Reasons to Purchase

- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available

Reports are normally delivered on the same day, via email, if purchased by debit/credit card. Reports purchased by invoice will be released when payment has been received. When you place an order through Google Checkout, Google Checkout will display a price approximation in your local currency. Keep in mind that you'll still be charged in the currency displayed on companiesandmarkets.com. Your debit/credit card company might convert the charge to your local currency and may also add additional fees that are not reflected in the approximate price displayed.

www.companiesandmarkets.com is a central source of market research reports from the world’s leading analysts and report publishers. Companiesandmarkets.com contains a comprehensive range of specialised market research reports from leading publishers for all market sectors.